Abstract
Plasma protein fibrinogen variants cause fibrinogen Aα-chain (AFib) amyloidosis, which presents with hypertension, proteinuria, and azotemia. Six AFib mutations have been reported thus far. We identified three patients who presented with marked proteinuria and serum creatinine elevations. Their kidney biopsies revealed destruction of the glomerular architecture by amyloid deposits with typical, apple-green birefringence in polarized light after Congo red staining. We found immunoreactivity against fibrinogen, which is typical for this type of amyloidosis. We sequenced the FGA exon 5 and demonstrated heterozygosity for the p.Glu526Val mutation in all three cases. This amino acid substitution is the most common fibrinogen Aα-chain variant causing AFib amyloidosis. The mutation has been reported in individuals of European and American descent but not yet in German patients. AFib amyloidosis should therefore be considered an important differential diagnosis in German patients with renal amyloidosis. In the cases described here, the use of antibodies directed against fibrinogen, followed by direct gene sequencing, revealed the underlying cause.
This is a preview of subscription content, access via your institution.


Abbreviations
- FGA:
-
fibrinogen Aα-chain gene
- HRA:
-
hereditary renal amyloidosis
- TTR:
-
transthyretin
- Fib:
-
fibrinogen Aα-chain
- Lys:
-
lysozyme
- ApoAI:
-
apolipoprotein AI
- ApoAII:
-
apolipoprotein AII
References
Alexander F, Atkins EL (1975) Familial renal amyloidosis. Case reports, literature review and classification. Am J Med 59:121–128
Benson MD (2005) Ostertag revisited: the inherited systemic amyloidoses without neuropathy. Amyloid 12:75–87
Benson MD, Kincaid JC (2007) The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 36:411–423
Benson MD, Liepnieks J, Uemichi T, Wheeler G, Correa R (1993) Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain. Nat Genet 3:252–255
Bohne S, Sletten K, Menard R, Buhling F, Vockler S, Wrenger E, Roessner A, Rocken C (2004) Cleavage of AL amyloid proteins and AL amyloid deposits by cathepsins B, K, and L. J Pathol 203:528–537
Bybee, A., Hollenbeck, M., Debusman, E., Gopaul, D., Gilbertson, J., and Lachmann, H. J. (2004) Hereditary renal amyloidosis in a German family associated with fibrinogen Aalhpa chain Glu540Val. In: Xth International Symposium on Amyloid and Amyloidosis, Tours, Loire Valley, France,71.
de Carvalho M, Linke RP, Domingos F, Evangelista T, Ducla-Soares JL, Nathrath WB, zevedo-Coutinho C, Lima R, Saraiva MJ (2004) Mutant fibrinogen A-alpha-chain associated with hereditary renal amyloidosis and peripheral neuropathy. Amyloid 11:200–207
Doolittle RF, Watt KW, Cottrell BA, Strong DD, Riley M (1979) The amino acid sequence of the alpha-chain of human fibrinogen. Nature 280:464–468
Gregorini G, Izzi C, Obici L, Tardanico R, Rocken C, Viola BF, Capistrano M, Donadei S, Biasi L, Scalvini T, Merlini G, Scolari F (2005) Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis. J Am Soc Nephrol 16:3680–3686
Hamidi AL, Liepnieks JJ, Uemichi T, Rebibou JM, Justrabo E, Droz D, Mousson C, Chalopin JM, Benson MD, Delpech M, Grateau G (1997) Renal amyloidosis with a frame shift mutation in fibrinogen a alpha-chain gene producing a novel amyloid protein. Blood 90:4799–4805
Hamidi AL, Fournier V, Billerey C, Justrabo E, Chevet D, Droz D, Pecheux C, Delpech M, Grateau G (1998) Fibrinogen A alpha chain mutation (Arg554 Leu) associated with hereditary renal amyloidosis in a French family. Amyloid 5:279–284
Hawkins PN (2003) Hereditary systemic amyloidosis with renal involvement. J Nephrol 16:443–448
Kang HG, Bybee A, Ha IS, Park MS, Gilbertson JA, Cheong HI, Choi Y, Hawkins PN (2005) Hereditary amyloidosis in early childhood associated with a novel insertion–deletion (indel) in the fibrinogen A alpha chain gene. Kidney Int 68:1994–1998
Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN (2002) Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 346:1786–1791
Mousson C, Heyd B, Justrabo E, Rebibou JM, Tanter Y, Miguet JP, Rifle G (2006) Successful hepatorenal transplantation in hereditary amyloidosis caused by a frame-shift mutation in fibrinogen A alpha-chain gene. Am J Transplant 6:632–635
Neerman-Arbez M (2006) Molecular basis of fibrinogen deficiency. Pathophysiol Haemost Thromb 35:187–198
Nichols WC, Dwulet FE, Liepnieks J, Benson MD (1988) Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun 156:762–768
Ostertag B (1950) Familiere amyloid-erkrankung. Zeitschrift für Menschliches Vererbungs und Konstitutionslehre 30:105–115
Serpell LC, Benson M, Liepnieks JJ, Fraser PE (2007) Structural analyses of fibrinogen amyloid fibrils. Amyloid 14:199–203
Uemichi T, Liepnieks JJ, Benson MD (1994) Hereditary renal amyloidosis with a novel variant fibrinogen. J Clin Invest 93:731–736
Uemichi T, Liepnieks JJ, Alexander F, Benson MD (1996) The molecular basis of renal amyloidosis in Irish–American and Polish–Canadian kindreds. QJM 89:745–750
Uemichi T, Liepnieks JJ, Yamada T, Gertz MA, Bang N, Benson MD (1996) A frame shift mutation in the fibrinogen A alpha chain gene in a kindred with renal amyloidosis. Blood 87:4197–4203
Uemichi T, Liepnieks JJ, Gertz MA, Benson MD (1998) Fibrinogen A alpha chain Leu 554: an African–American kindred with late onset renal amyloidosis. Amyloid 5:188–192
Zeldenrust S, Gertz M, Uemichi T, Bjornsson J, Wiesner R, Schwab T, Benson M (2003) Orthotopic liver transplantation for hereditary fibrinogen amyloidosis. Transplantation 75:560–561
Acknowledgements
This project was supported by grants of the European Union (EU FP6 EURAMY). We wish to thank Dr. August (Münster), Prof. Krenn (Trier) and Prof. Waldherr (Heidelberg) for kindly providing the kidney biopsies for immunohistochemical analyses, Dr. Thomas Ackermann (Mechernich) and Dr. Kerstin Traser (Halle/Saale) for admission of the patients and Prof. Luft (Berlin) for his critical revision of the manuscript.
Conflict of interest statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eriksson, M., Schönland, S., Bergner, R. et al. Three German fibrinogen Aα-chain amyloidosis patients with the p.Glu526Val mutation. Virchows Arch 453, 25–31 (2008). https://doi.org/10.1007/s00428-008-0619-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-008-0619-4